RNA-binding proteins as molecular links between cancer and neurodegeneration

Biogerontology

Volumn 15, Issue 6, 2014, Pages 587-610

  Campos Melo, Danae ^a   Droppelmann, Cristian A ^a   Volkening, Kathryn ^a,c   Strong, Michael J ^a,b,c,d  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c WESTERN UNIVERSITY   (Canada)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Cancer; Neurodegeneration; RNA metabolism; RNA binding proteins

Indexed keywords

ANGIOGENIN; FRAGILE X MENTAL RETARDATION PROTEIN; FUSED IN SARCOMA PROTEIN; HU PROTEIN; MESSENGER RNA; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR; RNA BINDING PROTEIN; RNA BINDING PROTEIN EWS; RNA SPECIFIC ADENOSINE DEAMINASE; TAR DNA BINDING PROTEIN; TATA BINDING PROTEIN ASSOCIATED FACTOR; TATA BINDING PROTEIN ASSOCIATED FACTOR 15; UNCLASSIFIED DRUG; ADENOSINE DEAMINASE; DNA BINDING PROTEIN; FMR1 PROTEIN, HUMAN; FUS PROTEIN, HUMAN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HU ANTIGEN; P190RHOGEF PROTEIN, HUMAN; PANCREATIC RIBONUCLEASE; RNA; TAF15 PROTEIN, HUMAN; TDP-43 PROTEIN, HUMAN;

CANCER GROWTH; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; DISEASE COURSE; GENE MUTATION; HUMAN; NEOPLASM; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; POLYADENYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RNA EDITING; RNA METABOLISM; RNA SPLICING; RNA STABILITY; RNA TRANSLATION; AGED; AGING; DEGENERATIVE DISEASE; GENETICS; METABOLISM;

ADENOSINE DEAMINASE; AGED; AGING; DNA-BINDING PROTEINS; FRAGILE X MENTAL RETARDATION PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; NEOPLASMS; NEURODEGENERATIVE DISEASES; RIBONUCLEASE, PANCREATIC; RNA, MESSENGER; RNA, NEOPLASM; RNA-BINDING PROTEIN EWS; RNA-BINDING PROTEIN FUS; RNA-BINDING PROTEINS; TATA-BINDING PROTEIN ASSOCIATED FACTORS;

EID: 84916630849     PISSN: 13895729     EISSN: 15736768     Source Type: Journal    
DOI: 10.1007/s10522-014-9531-2     Document Type: Review

References (268)

1. Abdelmohsen K et al (2007) Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell 25:543–557. doi:10.1016/j.molcel.2007.01.011
2. Aizawa H et al (2010) TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2. Acta Neuropathol 120:75–84. doi:10.1007/s00401-010-0678-x
3. Akamatsu W et al (2005) The RNA-binding protein HuD regulates neuronal cell identity and maturation. Proc Natl Acad Sci USA 102:4625–4630. doi:10.1073/pnas.0407523102
4. Akbarian S, Smith MA, Jones EG (1995) Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer’s disease. Huntington’s disease and schizophrenia Brain Res 699:297–304
5. Akool el S, Kleinert H, Hamada FM, Abdelwahab MH, Forstermann U, Pfeilschifter J, Eberhardt W (2003) Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR. Mol Cell Biol 23:4901–4916
6. Amadio M et al (2009) nELAV proteins alteration in Alzheimer’s disease brain: a novel putative target for amyloid-beta reverberating on AbetaPP processing. J Alzheimers Dis 16:409–419. doi:10.3233/JAD-2009-0967
7. Amador-Ortiz C et al (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease. Ann Neurol 61:435–445. doi:10.1002/ana.21154
8. Aman P et al (1996) Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics 37:1–8. doi:10.1006/geno.1996.0513
9. Anderson KD, Sengupta J, Morin M, Neve RL, Valenzuela CF, Perrone-Bizzozero NI (2001) Overexpression of HuD accelerates neurite outgrowth and increases GAP-43 mRNA expression in cortical neurons and retinoic acid-induced embryonic stem cells in vitro. Exp Neurol 168:250–258. doi:10.1006/exnr.2000.7599
10. Antar LN, Afroz R, Dictenberg JB, Carroll RC, Bassell GJ (2004) Metabotropic glutamate receptor activation regulates fragile X mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses. J Neurosci 24:2648–2655. doi:10.1523/JNEUROSCI.0099-04.2004
11. Antar LN, Dictenberg JB, Plociniak M, Afroz R, Bassell GJ (2005) Localization of FMRP-associated mRNA granules and requirement of microtubules for activity-dependent trafficking in hippocampal neurons. Genes Brain Behav 4:350–359. doi:10.1111/j.1601-183X.2005.00128.x
12. Antic D, Keene JD (1997) Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression. Am J Hum Genet 61:273–278. doi:10.1086/514866
13. Antic D, Lu N, Keene JD (1999) ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurites in human teratocarcinoma cells. Genes Dev 13:449–461
14. Arai T et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602–611. doi:10.1016/j.bbrc.2006.10.093
15. Attwooll C, Tariq M, Harris M, Coyne JD, Telford N, Varley JM (1999) Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma. Oncogene 18:7599–7601. doi:10.1038/sj.onc.1203156
16. Aurias A, Dutrillaux B, Griscelli C (1983) Tandem translocation t(14;14) in isolated and clonal cells in ataxia telangiectasia are different. Hum Genet 63:320–322
17. Avesson L, Barry G (2014) The emerging role of RNA and DNA editing in cancer. Biochim Biophys Acta 1845:308–316. doi:10.1016/j.bbcan.2014.03.001
18. Ayala YM, Misteli T, Baralle FE (2008) TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression. Proc Natl Acad Sci USA 105:3785–3789. doi:10.1073/pnas.0800546105
19. Ballarino M, Jobert L, Dembele D, de la Grange P, Auboeuf D, Tora L (2013) TAF15 is important for cellular proliferation and regulates the expression of a subset of cell cycle genes through miRNAs. Oncogene 32:4646–4655. doi:10.1038/onc.2012.490
20. Bechara EG et al (2009) A novel function for fragile X mental retardation protein in translational activation. PLoS Biol 7:e16. doi:10.1371/journal.pbio.1000016
21. Beckel-Mitchener AC, Miera A, Keller R, Perrone-Bizzozero NI (2002) Poly(A) tail length-dependent stabilization of GAP-43 mRNA by the RNA-binding protein HuD. J Biol Chem 277:27996–28002. doi:10.1074/jbc.M201982200
22. Bertolotti A, Lutz Y, Heard DJ, Chambon P, Tora L (1996) hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J 15:5022–5031
23. Bertolotti A, Melot T, Acker J, Vigneron M, Delattre O, Tora L (1998) EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes. Mol Cell Biol 18:1489–1497
24. Bertolotti A, Bell B, Tora L (1999) The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties. Oncogene 18:8000–8010. doi:10.1038/sj.onc.1203207
25. Blair IP et al (2010) FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis. J Neurol Neurosurg Psychiatry 81:639–645. doi:10.1136/jnnp.2009.194399
26. Blaxall BC, Dwyer-Nield LD, Bauer AK, Bohlmeyer TJ, Malkinson AM, Port JD (2000) Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue. Mol Carcinog 28:76–83. doi:10.1002/1098-2744(200006)
27. Blechingberg J, Luo Y, Bolund L, Damgaard CK, Nielsen AL (2012) Gene expression responses to FUS, EWS, and TAF15 reduction and stress granule sequestration analyses identifies FET-protein non-redundant functions. PLoS One 7:e46251. doi:10.1371/journal.pone.0046251
28. Brooke GN et al (2011) FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth. Cancer Res 71:914–924. doi:10.1158/0008-5472.CAN-10-0874
29. Budovsky A, Fraifeld VE, Aronov S (2011) Linking cell polarity, aging and rejuvenation. Biogerontology 12:167–175. doi:10.1007/s10522-010-9305-4
30. Buratti E, Baralle FE (2008) Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci 13:867–878
31. Buratti E, Dork T, Zuccato E, Pagani F, Romano M, Baralle FE (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J 20:1774–1784. doi:10.1093/emboj/20.7.1774
32. Campisi J, d’Adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8:729–740. doi:10.1038/nrm2233
33. Canete-Soler R, Schwartz ML, Hua Y, Schlaepfer WW (1998) Stability determinants are localized to the 3′-untranslated region and 3′-coding region of the neurofilament light subunit mRNA using a tetracycline-inducible promoter. J Biol Chem 273:12650–12654
34. Canete-Soler R, Wu J, Zhai J, Shamim M, Schlaepfer WW (2001) p190RhoGEF binds to a destabilizing element in the 3′ untranslated region of light neurofilament subunit mRNA and alters the stability of the transcript. J Biol Chem 276:32046–32050. doi:10.1074/jbc.M104104200
35. Cassiday LA, Maher LJ 3rd (2002) Having it both ways: transcription factors that bind DNA and RNA. Nucleic Acids Res 30:4118–4126
36. Caudy AA, Myers M, Hannon GJ, Hammond SM (2002) Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev 16:2491–2496. doi:10.1101/gad.1025202
37. Cenci C et al (2008) Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J Biol Chem 283:7251–7260. doi:10.1074/jbc.M708316200
38. Chan TH et al (2014) A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma. Gut 63:832–843. doi:10.1136/gutjnl-2012-304037
39. Chang N et al (2010) HuR uses AUF1 as a cofactor to promote p16INK4 mRNA decay. Mol Cell Biol 30:3875–3886. doi:10.1128/MCB.00169-10
40. Chen Y, Varani G (2005) Protein families and RNA recognition. FEBS J 272:2088–2097. doi:10.1111/j.1742-4658.2005.04650.x
41. Chen L, Yun SW, Seto J, Liu W, Toth M (2003) The fragile X mental retardation protein binds and regulates a novel class of mRNAs containing U rich target sequences. Neuroscience 120:1005–1017
42. Cho SJ, Zhang J, Chen X (2010) RNPC1 modulates the RNA-binding activity of, and cooperates with, HuR to regulate p21 mRNA stability. Nucleic Acids Res 38:2256–2267. doi:10.1093/nar/gkp1229
43. Cho J, Shen H, Yu H, Li H, Cheng T, Lee SB, Lee BC (2011) Ewing sarcoma gene Ews regulates hematopoietic stem cell senescence. Blood 117:1156–1166. doi:10.1182/blood-2010-04-279349
44. Corrado L et al (2010) Mutations of FUS gene in sporadic amyotrophic lateral sclerosis. J Med Genet 47:190–194. doi:10.1136/jmg.2009.071027
45. Couthouis J et al (2011) A yeast functional screen predicts new candidate ALS disease genes. Proc Natl Acad Sci USA 108:20881–20890. doi:10.1073/pnas.1109434108
46. Couthouis J et al (2012) Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum Mol Genet 21:2899–2911. doi:10.1093/hmg/dds116
47. Crozat A, Aman P, Mandahl N, Ron D (1993) Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363:640–644. doi:10.1038/363640a0
48. D’Alessandro V et al (2010) Molecular analysis of the HuD gene in neuroendocrine lung cancers. Lung Cancer 67:69–75. doi:10.1016/j.lungcan.2009.03.022
49. Dalmau J, Furneaux HM, Cordon-Cardo C, Posner JB (1992) The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol 141:881–886
50. Darnell JC, Jensen KB, Jin P, Brown V, Warren ST, Darnell RB (2001) Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107:489–499
51. DeJesus-Hernandez M et al (2010) De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis. Hum Mutat 31:E1377–E1389. doi:10.1002/humu.21241
52. Delattre O et al (1992) Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162–165. doi:10.1038/359162a0
53. Denkert C et al (2004) Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Cancer Res 64:189–195
54. D’Hulst C, Kooy RF (2009) Fragile X syndrome: from molecular genetics to therapy. J Med Genet 46:577–584. doi:10.1136/jmg.2008.064667
55. Driver JA, Logroscino G, Buring JE, Gaziano JM, Kurth T (2007) A prospective cohort study of cancer incidence following the diagnosis of Parkinson’s disease. Cancer Epidemiol Biomarkers Prev 16:1260–1265. doi:10.1158/1055-9965.EPI-07-0038
56. Droppelmann CA, Keller BA, Campos-Melo D, Volkening K, Strong MJ (2013a) Rho guanine nucleotide exchange factor is an NFL mRNA destabilizing factor that forms cytoplasmic inclusions in amyotrophic lateral sclerosis. Neurobiol Aging 34:248–262. doi:10.1016/j.neurobiolaging.2012.06.021
57. Droppelmann CA, Wang J, Campos-Melo D, Keller B, Volkening K, Hegele RA, Strong MJ (2013b) Detection of a novel frameshift mutation and regions with homozygosis within ARHGEF28 gene in familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 14:444–451. doi:10.3109/21678421.2012.758288
58. Droppelmann CA, Campos-Melo D, Ishtiaq M, Volkening K, Strong MJ (2014) RNA metabolism in ALS: When normal processes become pathological. Amyotroph Lateral Scler Frontotemporal Degener. doi:10.3109/21678421.2014.881377
59. Dutertre M, Lambert S, Carreira A, Amor-Gueret M, Vagner S (2014) DNA damage: RNA-binding proteins protect from near and far. Trends Biochem Sci 39:141–149. doi:10.1016/j.tibs.2014.01.003
60. Emara MM et al (2010) Angiogenin-induced tRNA-derived stress-induced RNAs promote stress-induced stress granule assembly. J Biol Chem 285:10959–10968. doi:10.1074/jbc.M109.077560
61. Evans HL (2011) Low-grade fibromyxoid sarcoma: a clinicopathologic study of 33 cases with long-term follow-up. Am J Surg Pathol 35:1450–1462. doi:10.1097/PAS.0b013e31822b3687
62. Farrer MJ et al (2009) DCTN1 mutations in Perry syndrome. Nat Genet 41:163–165. doi:10.1038/ng.293
63. Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL (1985) Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24:5480–5486
64. Filippova N et al (2011) The RNA-binding protein HuR promotes glioma growth and treatment resistance. Mol Cancer Res 9:648–659. doi:10.1158/1541-7786.MCR-10-0325
65. Flanagan JM, Funes JM, Henderson S, Wild L, Carey N, Boshoff C (2009) Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets. Mol Cancer Ther 8:249–260. doi:10.1158/1535-7163.MCT-08-0636
66. Freedman DM, Curtis RE, Daugherty SE, Goedert JJ, Kuncl RW, Tucker MA (2013) The association between cancer and amyotrophic lateral sclerosis. Cancer Causes Control 24:55–60. doi:10.1007/s10552-012-0089-5
67. Freeman SH, Spires-Jones T, Hyman BT, Growdon JH, Frosch MP (2008) TAR-DNA binding protein 43 in Pick disease. J Neuropathol Exp Neurol 67:62–67. doi:10.1097/nen.0b013e3181609361
68. Freibaum BD, Chitta RK, High AA, Taylor JP (2010) Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res 9:1104–1120. doi:10.1021/pr901076y
69. Galeano F et al (2013) ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis. Oncogene 32:998–1009. doi:10.1038/onc.2012.125
70. Gardiner M, Toth R, Vandermoere F, Morrice NA, Rouse J (2008) Identification and characterization of FUS/TLS as a new target of ATM. Biochem J 415:297–307. doi:10.1042/BJ20081135
71. Gebbink MF, Kranenburg O, Poland M, van Horck FP, Houssa B, Moolenaar WH (1997) Identification of a novel, putative Rho-specific GDP/GTP exchange factor and a RhoA-binding protein: control of neuronal morphology. J Cell Biol 137:1603–1613
72. Gendron TF, Rademakers R, Petrucelli L (2013) TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43. J Alzheimers Dis 33 Suppl 1:S35–S45. doi:10.3233/JAD-2012-129036
73. Geser F et al (2008) Pathological TDP-43 in parkinsonism–dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol 115:133–145. doi:10.1007/s00401-007-0257-y
74. Gitcho MA et al (2008) TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 63:535–538. doi:10.1002/ana.21344
75. Glisovic T, Bachorik JL, Yong J, Dreyfuss G (2008) RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett 582:1977–1986. doi:10.1016/j.febslet.2008.03.004
76. Gray MW (2012) Evolutionary origin of RNA editing. Biochemistry 51:5235–5242. doi:10.1021/bi300419r
77. Greaves MF, Wiemels J (2003) Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 3:639–649. doi:10.1038/nrc1164
78. Greco CM et al (2002) Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 125:1760–1771
79. Greenway MJ et al (2006) ANG mutations segregate with familial and ‘sporadic’ amyotrophic lateral sclerosis. Nat Genet 38:411–413. doi:10.1038/ng1742
80. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R (2004) The microprocessor complex mediates the genesis of microRNAs. Nature 432:235–240. doi:10.1038/nature03120
81. Hagerman RJ, Hagerman PJ (2002) The fragile X premutation: into the phenotypic fold. Curr Opin Genet Dev 12:278–283
82. Haile S, Lal A, Myung JK, Sadar MD (2011) FUS/TLS is a co-activator of androgen receptor in prostate cancer cells. PLoS ONE 6:e24197. doi:10.1371/journal.pone.0024197
83. Han JH, Yu TH, Ryu HH, Jun MH, Ban BK, Jang DJ, Lee JA (2013) ALS/FTLD-linked TDP-43 regulates neurite morphology and cell survival in differentiated neurons. Exp Cell Res 319:1998–2005. doi:10.1016/j.yexcr.2013.05.025
84. Harper JW, Vallee BL (1989) A covalent angiogenin/ribonuclease hybrid with a fourth disulfide bond generated by regional mutagenesis. Biochemistry 28:1875–1884
85. Hartner JC, Schmittwolf C, Kispert A, Muller AM, Higuchi M, Seeburg PH (2004) Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J Biol Chem 279:4894–4902. doi:10.1074/jbc.M311347200
86. Hartner JC, Walkley CR, Lu J, Orkin SH (2009) ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat Immunol 10:109–115. doi:10.1038/ni.1680
87. Hasegawa M et al (2007) TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain 130:1386–1394. doi:10.1093/brain/awm065
88. Hashem V, Galloway JN, Mori M, Willemsen R, Oostra BA, Paylor R, Nelson DL (2009) Ectopic expression of CGG containing mRNA is neurotoxic in mammals. Hum Mol Genet 18:2443–2451. doi:10.1093/hmg/ddp182
89. Hashimoto M, Tsugawa T, Kawagishi H, Asai A, Sugimoto M (2014) Loss of HuR leads to senescence-like cytokine induction in rodent fibroblasts by activating NF-kappaB. Biochim Biophys Acta 1840:3079–3087. doi:10.1016/j.bbagen.2014.07.005
90. Herrup K, Yang Y (2007) Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nat Rev Neurosci 8:368–378. doi:10.1038/nrn2124
91. Hideyama T, Yamashita T, Aizawa H, Tsuji S, Kakita A, Takahashi H, Kwak S (2012) Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons. Neurobiol Dis 45:1121–1128. doi:10.1016/j.nbd.2011.12.033
92. Higashi S et al (2007) Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer’s disease and dementia with Lewy bodies. Brain Res 1184:284–294. doi:10.1016/j.brainres.2007.09.048
93. Higashi S, Kabuta T, Nagai Y, Tsuchiya Y, Akiyama H, Wada K (2013) TDP-43 associates with stalled ribosomes and contributes to cell survival during cellular stress. J Neurochem 126:288–300. doi:10.1111/jnc.12194
94. Hinman MN, Lou H (2008) Diverse molecular functions of Hu proteins. Cell Mol Life Sci 65:3168–3181. doi:10.1007/s00018-008-8252-6
95. Hisaoka M, Okamoto S, Yokoyama K, Hashimoto H (2004) Coexpression of NOR1 and SIX3 proteins in extraskeletal myxoid chondrosarcomas without detectable NR4A3 fusion genes. Cancer Genet Cytogenet 152:101–107. doi:10.1016/j.cancergencyto.2003.11.011
96. Hogg M, Paro S, Keegan LP, O’Connell MA (2011) RNA editing by mammalian ADARs. Adv Genet 73:87–120. doi:10.1016/B978-0-12-380860-8.00003-3
97. Hu HM, Zielinska-Kwiatkowska A, Munro K, Wilcox J, Wu DY, Yang L, Chansky HA (2008a) EWS/FLI1 suppresses retinoblastoma protein function and senescence in Ewing’s sarcoma cells. J Orthop Res 26:886–893. doi:10.1002/jor.20597
98. Hu WT, Josephs KA, Knopman DS, Boeve BF, Dickson DW, Petersen RC, Parisi JE (2008b) Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease. Acta Neuropathol 116:215–220. doi:10.1007/s00401-008-0400-4
99. Ibaragi S, Yoshioka N, Li S, Hu MG, Hirukawa S, Sadow PM, Hu GF (2009) Neamine inhibits prostate cancer growth by suppressing angiogenin-mediated rRNA transcription. Clin Cancer Res 15:1981–1988. doi:10.1158/1078-0432.CCR-08-2593
100. Ichikawa H, Shimizu K, Hayashi Y, Ohki M (1994) An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res 54:2865–2868
101. Inzelberg R, Israeli-Korn SD (2009) The particular relationship between Parkinson’s disease and malignancy: a focus on skin cancers. J Neural Transm 116:1503–1507. doi:10.1007/s00702-009-0322-x
102. Inzelberg R, Jankovic J (2007) Are Parkinson disease patients protected from some but not all cancers? Neurology 69:1542–1550. doi:10.1212/01.wnl.0000277638.63767.b8
103. Ishizuka A, Siomi MC, Siomi H (2002) A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes Dev 16:2497–2508. doi:10.1101/gad.1022002
104. Ivanov P, Emara MM, Villen J, Gygi SP, Anderson P (2011) Angiogenin-induced tRNA fragments inhibit translation initiation. Mol Cell 43:613–623. doi:10.1016/j.molcel.2011.06.022
105. Izquierdo JM (2008) Hu antigen R (HuR) functions as an alternative pre-mRNA splicing regulator of Fas apoptosis-promoting receptor on exon definition. J Biol Chem 283:19077–19084. doi:10.1074/jbc.M800017200
106. Jacobs MM, Fogg RL, Emeson RB, Stanwood GD (2009) ADAR1 and ADAR2 expression and editing activity during forebrain development. Dev Neurosci 31:223–237. doi:10.1159/000210185
107. Jacquemont S et al (2004) Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 291:460–469. doi:10.1001/jama.291.4.460
108. Jain RG, Andrews LG, McGowan KM, Pekala PH, Keene JD (1997) Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes. Mol Cell Biol 17:954–962
109. Jain RG, Andrews LG, McGowan KM, Gao F, Keene JD, Pekala PP (1995) Hel-N1, an RNA-binding protein, is a ligand for an A + U rich region of the GLUT1 3′ UTR. Nucleic Acids Symp Ser 33:209–211
110. Jin P, Zarnescu DC, Zhang F, Pearson CE, Lucchesi JC, Moses K, Warren ST (2003) RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron 39:739–747
111. Jin P et al (2007) Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron 55:556–564. doi:10.1016/j.neuron.2007.07.020
112. Jobert L, Pinzon N, Van Herreweghe E, Jady BE, Guialis A, Kiss T, Tora L (2009) Human U1 snRNA forms a new chromatin-associated snRNP with TAF15. EMBO Rep 10:494–500. doi:10.1038/embor.2009.24
113. Kabashi E et al (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40:572–574. doi:10.1038/ng.132
114. Kawahara Y, Mieda-Sato A (2012) TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci USA 109:3347–3352. doi:10.1073/pnas.1112427109
115. Keller BA, Volkening K, Droppelmann CA, Ang LC, Rademakers R, Strong MJ (2012) Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism. Acta Neuropathol 124:733–747. doi:10.1007/s00401-012-1035-z
116. Kieran D et al (2008) Control of motoneuron survival by angiogenin. J Neurosci 28:14056–14061. doi:10.1523/JNEUROSCI.3399-08.2008
117. Kim SH, Shanware NP, Bowler MJ, Tibbetts RS (2010) Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA. J Biol Chem 285:34097–34105. doi:10.1074/jbc.M110.154831
118. Kim KY et al (2014) A multifunctional protein EWS regulates the expression of Drosha and microRNAs. Cell Death Differ 21:136–145. doi:10.1038/cdd.2013.144
119. Kishimoto K, Liu S, Tsuji T, Olson KA, Hu GF (2005) Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 24:445–456. doi:10.1038/sj.onc.1208223
120. Knoop LL, Baker SJ (2000) The splicing factor U1C represses EWS/FLI-mediated transactivation. J Biol Chem 275:24865–24871. doi:10.1074/jbc.M001661200
121. Kong XT et al (1997) Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript. Blood 90:1192–1199
122. Kruman II et al (2004) Cell cycle activation linked to neuronal cell death initiated by DNA damage. Neuron 41:549–561
123. Kwak S, Kawahara Y (2005) Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis. J Mol Med (Berl) 83:110–120. doi:10.1007/s00109-004-0599-z
124. Kwiatkowski TJ, Jr. et al (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323:1205–1208. doi:10.1126/science.1166066
125. Laggerbauer B, Ostareck D, Keidel EM, Ostareck-Lederer A, Fischer U (2001) Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum Mol Genet 10:329–338
126. Lai SL et al (2011) FUS mutations in sporadic amyotrophic lateral sclerosis. Neurobiol Aging 32(550):e551–e554. doi:10.1016/j.neurobiolaging.2009.12.020
127. Lal A, Kawai T, Yang X, Mazan-Mamczarz K, Gorospe M (2005) Antiapoptotic function of RNA-binding protein HuR effected through prothymosin alpha. EMBO J 24:1852–1862. doi:10.1038/sj.emboj.7600661
128. Law WJ, Cann KL, Hicks GG (2006) TLS, EWS and TAF15: a model for transcriptional integration of gene expression. Brief Funct Genomic Proteomic 5:8–14. doi:10.1093/bfgp/ell015
129. Lee MH, Yang HY (2003) Regulators of G1 cyclin-dependent kinases and cancers. Cancer Metastasis Rev 22:435–449
130. Leichter M, Marko M, Ganou V, Patrinou-Georgoula M, Tora L, Guialis A (2011) A fraction of the transcription factor TAF15 participates in interactions with a subset of the spliceosomal U1 snRNP complex. Biochim Biophys Acta 1814:1812–1824. doi:10.1016/j.bbapap.2011.09.008
131. Li S, Hu GF (2010) Angiogenin-mediated rRNA transcription in cancer and neurodegeneration Int. J Biochem Mol Biol 1:26–35
132. Li S, Hu GF (2012) Emerging role of angiogenin in stress response and cell survival under adverse conditions. J Cell Physiol 227:2822–2826. doi:10.1002/jcp.23051
133. Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J, Xue Q (2003) Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol 129:43–51. doi:10.1007/s00432-002-0396-4
134. Li H et al (2007) Ewing sarcoma gene EWS is essential for meiosis and B lymphocyte development. J Clin Invest 117:1314–1323. doi:10.1172/JCI31222
135. Li X, Lu L, Bush DJ, Zhang X, Zheng L, Suswam EA, King PH (2009) Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to adenine/uridine-rich stability elements in the vascular endothelial growth factor 3′-untranslated region. J Neurochem 108:1032–1044. doi:10.1111/j.1471-4159.2008.05856.x
136. Lin H, Zhai J, Schlaepfer WW (2005) RNA-binding protein is involved in aggregation of light neurofilament protein and is implicated in the pathogenesis of motor neuron degeneration. Hum Mol Genet 14:3643–3659. doi:10.1093/hmg/ddi392
137. Ling SC, Albuquerque CP, Han JS, Lagier-Tourenne C, Tokunaga S, Zhou H, Cleveland DW (2010) ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc Natl Acad Sci USA 107:13318–13323. doi:10.1073/pnas.1008227107
138. Liu Y et al (2007) Identification of differential expression of genes in hepatocellular carcinoma by suppression subtractive hybridization combined cDNA microarray. Oncol Rep 18:943–951
139. Lopez de Silanes I, Fan J, Yang X, Zonderman AB, Potapova O, Pizer ES, Gorospe M (2003) Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene 22:7146–7154. doi:10.1038/sj.onc.1206862
140. Lopez de Silanes I, Fan J, Galban CJ, Spencer RG, Becker KG, Gorospe M (2004) Global analysis of HuR-regulated gene expression in colon cancer systems of reducing complexity. Gene Expr 12:49–59
141. Lu L et al (2009) Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR): implications for impaired post-transcriptional regulation of vascular endothelial growth factor. J Biol Chem 284:33989–33998. doi:10.1074/jbc.M109.067918
142. Luca R et al (2013) The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation. EMBO Mol Med 5:1523–1536. doi:10.1002/emmm.201302847
143. Lunde BM, Moore C, Varani G (2007) RNA-binding proteins: modular design for efficient function. Nat Rev Mol Cell Biol 8:479–490. doi:10.1038/nrm2178
144. Ma Y et al (2014) ARHGEF28 gene exon 6/intron 6 junction mutations in Chinese amyotrophic lateral sclerosis cohort. Amyotroph Lateral Scler Frontotemporal Degener 15:309–311. doi:10.3109/21678421.2014.896926
145. Maas S, Patt S, Schrey M, Rich A (2001) Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc Natl Acad Sci USA 98:14687–14692. doi:10.1073/pnas.251531398
146. Macbeth MR, Schubert HL, Vandemark AP, Lingam AT, Hill CP, Bass BL (2005) Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing. Science 309:1534–1539. doi:10.1126/science.1113150
147. Maekawa S et al (2009) TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations. Neuropathology 29:672–683. doi:10.1111/j.1440-1789.2009.01029.x
148. Mallela A, Nishikura K (2012) A-to-I editing of protein coding and noncoding RNAs. Crit Rev Biochem Mol Biol 47:493–501. doi:10.3109/10409238.2012.714350
149. Marko M, Leichter M, Patrinou-Georgoula M, Guialis A (2014) Selective interactions of hnRNP M isoforms with the TET proteins TAF15 and TLS/FUS. Mol Biol Rep 41:2687–2695. doi:10.1007/s11033-014-3128-3
150. Martini A et al (2002) Recurrent rearrangement of the Ewing’s sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia. Cancer Res 62:5408–5412
151. Mastrocola AS, Kim SH, Trinh AT, Rodenkirch LA, Tibbetts RS (2013) The RNA-binding protein fused in sarcoma (FUS) functions downstream of poly(ADP-ribose) polymerase (PARP) in response to DNA damage. J Biol Chem 288:24731–24741. doi:10.1074/jbc.M113.497974
152. Mazan-Mamczarz K, Galban S, Lopez de Silanes I, Martindale JL, Atasoy U, Keene JD, Gorospe M (2003) RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc Natl Acad Sci USA 100:8354–8359. doi:10.1073/pnas.1432104100
153. Mazan-Mamczarz K et al (2008) Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype. Oncogene 27:6151–6163. doi:10.1038/onc.2008.215
154. Mazroui R, Huot ME, Tremblay S, Filion C, Labelle Y, Khandjian EW (2002) Trapping of messenger RNA by fragile X mental retardation protein into cytoplasmic granules induces translation repression. Hum Mol Genet 11:3007–3017
155. Mazroui R et al (2008) Caspase-mediated cleavage of HuR in the cytoplasm contributes to pp32/PHAP-I regulation of apoptosis. J Cell Biol 180:113–127. doi:10.1083/jcb.200709030
156. Melcher T, Maas S, Herb A, Sprengel R, Higuchi M, Seeburg PH (1996) RED2, a brain-specific member of the RNA-specific adenosine deaminase family. J Biol Chem 271:31795–31798
157. Miklossy J, Steele JC, Yu S, McCall S, Sandberg G, McGeer EG, McGeer PL (2008) Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC). Acta Neuropathol 116:625–637. doi:10.1007/s00401-008-0439-2
158. Milani P et al (2013) Posttranscriptional regulation of SOD1 gene expression under oxidative stress: potential role of ELAV proteins in sporadic ALS. Neurobiol Dis 60:51–60. doi:10.1016/j.nbd.2013.08.005
159. Miller NL, Lawson C, Chen XL, Lim ST, Schlaepfer DD (2012) Rgnef (p190RhoGEF) knockout inhibits RhoA activity, focal adhesion establishment, and cell motility downstream of integrins. PLoS One 7:e37830. doi:10.1371/journal.pone.0037830
160. Moller H, Mellemkjaer L, McLaughlin JK, Olsen JH (1995) Occurrence of different cancers in patients with Parkinson’s disease. BMJ 310:1500–1501
161. Morlando M, Dini Modigliani S, Torrelli G, Rosa A, Di Carlo V, Caffarelli E, Bozzoni I (2012) FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J 31:4502–4510. doi:10.1038/emboj.2012.319
162. Munoz DG et al (2009) FUS pathology in basophilic inclusion body disease. Acta Neuropathol 118:617–627. doi:10.1007/s00401-009-0598-9
163. Musicco M et al (2013) Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study. Neurology 81:322–328. doi:10.1212/WNL.0b013e31829c5ec1
164. Nakashima-Yasuda H et al (2007) Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol 114:221–229. doi:10.1007/s00401-007-0261-2
165. Nan YN, Zhu JY, Tan Y, Zhang Q, Jia W, Hua Q (2014) Staurosporine induced apoptosis rapidly downregulates TDP-43 in glioma cells. Asian Pac J Cancer Prev 15:3575–3579
166. Neumann M et al (2011) FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain 134:2595–2609. doi:10.1093/brain/awr201
167. Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, Mackenzie IR (2009a) A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132:2922–2931. doi:10.1093/brain/awp214
168. Neumann M, Roeber S, Kretzschmar HA, Rademakers R, Baker M, Mackenzie IR (2009b) Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol 118:605–616. doi:10.1007/s00401-009-0581-5
169. Neumann M et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133. doi:10.1126/science.1134108
170. Nie Z, Wu J, Zhai J, Lin H, Ge W, Schlaepfer WW, Canete-Soler R (2002) Untranslated element in neurofilament mRNA has neuropathic effect on motor neurons of transgenic mice. J Neurosci 22:7662–7670
171. Noureddine MA et al (2005) Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease. Hum Genet 117:27–33. doi:10.1007/s00439-005-1259-2
172. Olsen JH, Friis S, Frederiksen K (2006) Malignant melanoma and other types of cancer preceding Parkinson disease. Epidemiology 17:582–587. doi:10.1097/01.ede.0000229445.90471.5e
173. O’Rourke DJ et al (2012) Autoantibody signatures as biomarkers to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate specific antigen. Clin Chim Acta 413:561–567. doi:10.1016/j.cca.2011.11.027
174. Orozco D, Tahirovic S, Rentzsch K, Schwenk BM, Haass C, Edbauer D (2012) Loss of fused in sarcoma (FUS) promotes pathological Tau splicing. EMBO Rep 13:759–764. doi:10.1038/embor.2012.90
175. Ou SH, Wu F, Harrich D, Garcia-Martinez LF, Gaynor RB (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 69:3584–3596
176. Panagopoulos I et al (1994) Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22). Genes Chromosomes Cancer 11:256–262
177. Panagopoulos I et al (2004) The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma. Genes Chromosomes Cancer 40:218–228. doi:10.1002/gcc.20037
178. Park YY et al (2013) Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520. Hepatology 58:182–191. doi:10.1002/hep.26310
179. Paronetto MP, Minana B, Valcarcel J (2011) The Ewing sarcoma protein regulates DNA damage-induced alternative splicing. Mol Cell 43:353–368. doi:10.1016/j.molcel.2011.05.035
180. Pereira DS et al (1998) Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells. Proc Natl Acad Sci USA 95:8239–8244
181. Perez-Losada J et al (2000a) The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice. Oncogene 19:2413–2422. doi:10.1038/sj.onc.1203572
182. Perez-Losada J et al (2000b) Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma. Oncogene 19:6015–6022. doi:10.1038/sj.onc.1204018
183. Pesiridis GS, Lee VM, Trojanowski JQ (2009) Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum Mol Genet 18:R156–R162. doi:10.1093/hmg/ddp303
184. Pfeiffer BE, Huber KM (2009) The state of synapses in fragile X syndrome. Neuroscientist 15:549–567. doi:10.1177/1073858409333075
185. Plun-Favreau H, Lewis PA, Hardy J, Martins LM, Wood NW (2010) Cancer and neurodegeneration: between the devil and the deep blue sea. PLoS Genet 6:e1001257. doi:10.1371/journal.pgen.1001257
186. Polymenidou M et al (2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 14:459–468. doi:10.1038/nn.2779
187. Postel-Vinay S et al (2012) Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma. Nat Genet 44:323–327. doi:10.1038/ng.1085
188. Qiu H et al (2014) ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J Clin Invest 124:981–999. doi:10.1172/JCI72723
189. Qiu W et al (2013) ADAR1 is essential for intestinal homeostasis and stem cell maintenance. Cell Death Dis 4:e599. doi:10.1038/cddis.2013.125
190. Quattrone A, Pascale A, Nogues X, Zhao W, Gusev P, Pacini A, Alkon DL (2001) Posttranscriptional regulation of gene expression in learning by the neuronal ELAV-like mRNA-stabilizing proteins. Proc Natl Acad Sci USA 98:11668–11673. doi:10.1073/pnas.191388398
191. Rabbitts TH, Forster A, Larson R, Nathan P (1993) Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet 4:175–180. doi:10.1038/ng0693-175
192. Ramos A, Hollingworth D, Pastore A (2003) G-quartet-dependent recognition between the FMRP RGG box and RNA. RNA 9:1198–1207
193. Reid R, de Silva MV, Paterson L, Ryan E, Fisher C (2003) Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes share a common t(7;16)(q34;p11) translocation. Am J Surg Pathol 27:1229–1236
194. Roe CM, Behrens MI, Xiong C, Miller JP, Morris JC (2005) Alzheimer disease and cancer. Neurology 64:895–898. doi:10.1212/01.WNL.0000152889.94785.51
195. Rossman KL, Der CJ, Sondek J (2005) GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 6:167–180. doi:10.1038/nrm1587
196. Sama RR, Ward CL, Kaushansky LJ, Lemay N, Ishigaki S, Urano F, Bosco DA (2013) FUS/TLS assembles into stress granules and is a prosurvival factor during hyperosmolar stress. J Cell Physiol 228:2222–2231. doi:10.1002/jcp.24395
197. Sanchez G, Bittencourt D, Laud K, Barbier J, Delattre O, Auboeuf D, Dutertre M (2008) Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer. Proc Natl Acad Sci USA 105:6004–6009. doi:10.1073/pnas.0710748105
198. Savva YA, Rieder LE, Reenan RA (2012) The ADAR protein family. Genome Biol 13:252. doi:10.1186/gb-2012-13-12-252
199. Schaeffer C, Bardoni B, Mandel JL, Ehresmann B, Ehresmann C, Moine H (2001) The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. EMBO J 20:4803–4813. doi:10.1093/emboj/20.17.4803
200. Schultz-Pedersen S, Hasle H, Olsen JH, Friedrich U (2001) Evidence of decreased risk of cancer in individuals with fragile X. Am J Med Genet 103:226–230. doi:10.1002/ajmg.1533
201. Schumacher JM, Lee K, Edelhoff S, Braun RE (1995) Distribution of Tenr, an RNA-binding protein, in a lattice-like network within the spermatid nucleus in the mouse. Biol Reprod 52:1274–1283
202. Sephton CF et al (2011) Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J Biol Chem 286:1204–1215. doi:10.1074/jbc.M110.190884
203. Seyfried NT et al (2010) Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains. Mol Cell Proteomics 9:705–718. doi:10.1074/mcp.M800390-MCP200
204. Shapiro R, Riordan JF, Vallee BL (1986) Characteristic ribonucleolytic activity of human angiogenin. Biochemistry 25:3527–3532
205. Sheflin LG, Zou AP, Spaulding SW (2004) Androgens regulate the binding of endogenous HuR to the AU-rich 3′UTRs of HIF-1alpha and EGF mRNA. Biochem Biophys Res Commun 322:644–651. doi:10.1016/j.bbrc.2004.07.173
206. Skorupa A et al (2012) Motoneurons secrete angiogenin to induce RNA cleavage in astroglia. J Neurosci 32:5024–5038. doi:10.1523/JNEUROSCI.6366-11.2012
207. Sofola OA et al (2007) RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS. Neuron 55:565–571. doi:10.1016/j.neuron.2007.07.021
208. Sommer B, Kohler M, Sprengel R, Seeburg PH (1991) RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67:11–19
209. Spitzer JI, Ugras S, Runge S, Decarolis P, Antonescu C, Tuschl T, Singer S (2011) mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma. Genes Chromosomes Cancer 50:338–347. doi:10.1002/gcc.20858
210. Sreedharan J et al (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319:1668–1672. doi:10.1126/science.1154584
211. Stefl R, Xu M, Skrisovska L, Emeson RB, Allain FH (2006) Structure and specific RNA binding of ADAR2 double-stranded RNA binding motifs. Structure 14:345–355. doi:10.1016/j.str.2005.11.013
212. Steidinger TU, Standaert DG, Yacoubian TA (2011) A neuroprotective role for angiogenin in models of Parkinson’s disease. J Neurochem 116:334–341. doi:10.1111/j.1471-4159.2010.07112.x
213. Streit WJ (2006) Microglial senescence: does the brain’s immune system have an expiration date? Trends Neurosci 29:506–510. doi:10.1016/j.tins.2006.07.001
214. Strong MJ, Volkening K (2011) TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis? FEBS J 278:3569–3577. doi:10.1111/j.1742-4658.2011.08277.x
215. Subramanian V, Feng Y (2007) A new role for angiogenin in neurite growth and pathfinding: implications for amyotrophic lateral sclerosis. Hum Mol Genet 16:1445–1453. doi:10.1093/hmg/ddm095
216. Subramanian V, Crabtree B, Acharya KR (2008) Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons. Hum Mol Genet 17:130–149. doi:10.1093/hmg/ddm290
217. Szabo A et al (1991) HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 67:325–333
218. Tan AY, Manley JL (2009) The TET family of proteins: functions and roles in disease J. Mol Cell Biol 1:82–92. doi:10.1093/jmcb/mjp025
219. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ (2000) Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 66:6–15. doi:10.1086/302720
220. Teittinen KJ et al (2012) Nucleolar proteins with altered expression in leukemic cell lines. Leuk Res 36:232–236. doi:10.1016/j.leukres.2011.06.038
221. Thomsen C, Grundevik P, Elias P, Stahlberg A, Aman P (2013) A conserved N-terminal motif is required for complex formation between FUS, EWSR1, TAF15 and their oncogenic fusion proteins. FASEB J 27:4965–4974. doi:10.1096/fj.13-234435
222. Ticozzi N et al (2011) Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am J Med Genet B 156B:285–290. doi:10.1002/ajmg.b.31158
223. Tollervey JR et al (2011) Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci 14:452–458. doi:10.1038/nn.2778
224. Tomaselli S et al (2013) ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas. BMC Cancer 13:255. doi:10.1186/1471-2407-13-255
225. Toomey EC, Schiffman JD, Lessnick SL (2010) Recent advances in the molecular pathogenesis of Ewing’s sarcoma. Oncogene 29:4504–4516. doi:10.1038/onc.2010.205
226. Tsuji T, Sun Y, Kishimoto K, Olson KA, Liu S, Hirukawa S, Hu GF (2005) Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation. Cancer Res 65:1352–1360. doi:10.1158/0008-5472.CAN-04-2058
227. Uranishi H, Tetsuka T, Yamashita M, Asamitsu K, Shimizu M, Itoh M, Okamoto T (2001) Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator. J Biol Chem 276:13395–13401. doi:10.1074/jbc.M011176200
228. Uryu K et al (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 67:555–564. doi:10.1097/NEN.0b013e31817713b5
229. Valles I et al (2012) Identification of novel deregulated RNA metabolism-related genes in non-small cell lung cancer. PLoS One 7:e42086. doi:10.1371/journal.pone.0042086
230. Van Deerlin VM et al (2008) TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol 7:409–416. doi:10.1016/S1474-4422(08)70071-1
231. van Es MA et al (2011) Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann Neurol 70:964–973. doi:10.1002/ana.22611
232. van Horck FP, Ahmadian MR, Haeusler LC, Moolenaar WH, Kranenburg O (2001) Characterization of p190RhoGEF, a RhoA-specific guanine nucleotide exchange factor that interacts with microtubules. J Biol Chem 276:4948–4956. doi:10.1074/jbc.M003839200
233. Vance C et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323:1208–1211 doi:10.1126/science.1165942
234. Volkening K, Leystra-Lantz C, Strong MJ (2010) Human low molecular weight neurofilament (NFL) mRNA interacts with a predicted p190RhoGEF homologue (RGNEF) in humans. Amyotroph Lateral Scler 11:97–103. doi:10.3109/17482960902995584
235. Wahlstedt H, Daniel C, Enstero M, Ohman M (2009) Large-scale mRNA sequencing determines global regulation of RNA editing during brain development. Genome Res 19:978–986. doi:10.1101/gr.089409.108
236. Wang Q, Khillan J, Gadue P, Nishikura K (2000a) Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 290:1765–1768
237. Wang W, Caldwell MC, Lin S, Furneaux H, Gorospe M (2000b) HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J 19:2340–2350. doi:10.1093/emboj/19.10.2340
238. Wang W, Yang X, Cristofalo VJ, Holbrook NJ, Gorospe M (2001) Loss of HuR is linked to reduced expression of proliferative genes during replicative senescence. Mol Cell Biol 21:5889–5898
239. Wang W, Yang X, Lopez de Silanes I, Carling D, Gorospe M (2003) Increased AMP:ATP ratio and AMP-activated protein kinase activity during cellular senescence linked to reduced HuR function. J Biol Chem 278:27016–27023. doi:10.1074/jbc.M300318200
240. Wang HY, Wang IF, Bose J, Shen CK (2004) Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics 83:130–139
241. Wang W, Martindale JL, Yang X, Chrest FJ, Gorospe M (2005) Increased stability of the p16 mRNA with replicative senescence. EMBO Rep 6:158–164. doi:10.1038/sj.embor.7400346
242. Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH (2009) TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA 106:18809–18814. doi:10.1073/pnas.0908767106
243. Whitney NP, Peng H, Erdmann NB, Tian C, Monaghan DT, Zheng JC (2008) Calcium-permeable AMPA receptors containing Q/R-unedited GluR2 direct human neural progenitor cell differentiation to neurons. FASEB J 22:2888–2900. doi:10.1096/fj.07-104661
244. Wider C et al (2009) Pallidonigral TDP-43 pathology in Perry syndrome. Parkinsonism Relat Disord 15:281–286. doi:10.1016/j.parkreldis.2008.07.005
245. Willemsen R et al (2003) The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. Hum Mol Genet 12:949–959
246. Wils H et al (2010) TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA 107:3858–3863. doi:10.1073/pnas.0912417107
247. Wu D et al (2007) Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann Neurol 62:609–617. doi:10.1002/ana.21221
248. Xu YF et al (2010) Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci 30:10851–10859. doi:10.1523/JNEUROSCI.1630-10.2010
249. XuFeng R et al (2009) ADAR1 is required for hematopoietic progenitor cell survival via RNA editing. Proc Natl Acad Sci USA 106:17763–17768. doi:10.1073/pnas.0903324106
250. Yacoubian TA, Cantuti-Castelvetri I, Bouzou B, Asteris G, McLean PJ, Hyman BT, Standaert DG (2008) Transcriptional dysregulation in a transgenic model of Parkinson disease. Neurobiol Dis 29:515–528. doi:10.1016/j.nbd.2007.11.008
251. Yamasaki S, Ivanov P, Hu GF, Anderson P (2009) Angiogenin cleaves tRNA and promotes stress-induced translational repression. J Cell Biol 185:35–42. doi:10.1083/jcb.200811106
252. Yan W, Zhang Y, Zhang J, Cho SJ, Chen X (2012) HuR is necessary for mammary epithelial cell proliferation and polarity at least in part via DeltaNp63. PLoS One 7:e45336. doi:10.1371/journal.pone.0045336
253. Yang L, Embree LJ, Tsai S, Hickstein DD (1998) Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J Biol Chem 273:27761–27764
254. Yang L, Embree LJ, Hickstein DD (2000) TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins. Mol Cell Biol 20:3345–3354
255. Yoshioka N, Wang L, Kishimoto K, Tsuji T, Hu GF (2006) A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation. Proc Natl Acad Sci USA 103:14519–14524. doi:10.1073/pnas.0606708103
256. Yu HG et al (2011) p190RhoGEF (Rgnef) promotes colon carcinoma tumor progression via interaction with focal adhesion kinase. Cancer Res 71:360–370. doi:10.1158/0008-5472.CAN-10-2894
257. Zalfa F et al (2005) Fragile X mental retardation protein (FMRP) binds specifically to the brain cytoplasmic RNAs BC1/BC200 via a novel RNA-binding motif. J Biol Chem 280:33403–33410. doi:10.1074/jbc.M504286200
258. Zalfa F et al (2007) A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nat Neurosci 10:578–587. doi:10.1038/nn1893
259. Zhai J, Lin H, Nie Z, Wu J, Canete-Soler R, Schlaepfer WW, Schlaepfer DD (2003) Direct interaction of focal adhesion kinase with p190RhoGEF. J Biol Chem 278:24865–24873. doi:10.1074/jbc.M302381200
260. Zhang D, Paley AJ, Childs G (1998) The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription. J Biol Chem 273:18086–18091
261. Zhang C et al (2014a) Cytoplasmic expression of the ELAV-like protein HuR as a potential prognostic marker in esophageal squamous cell carcinoma. Tumour Biol 35:73–80. doi:10.1007/s13277-013-1008-4
262. Zhang W, Cheng Y, Li Y, Chen Z, Jin P, Chen D (2014b) A feed-forward mechanism involving Drosophila fragile X mental retardation protein triggers a replication stress-induced DNA damage response. Hum Mol Genet. doi:10.1093/hmg/ddu241
263. Zhou HL et al (2011) Hu proteins regulate alternative splicing by inducing localized histone hyperacetylation in an RNA-dependent manner. Proc Natl Acad Sci USA 108:E627–E635. doi:10.1073/pnas.1103344108
264. Zhou Y, Liu S, Liu G, Ozturk A, Hicks GG (2013) ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation. PLoS Genet 9:e1003895. doi:10.1371/journal.pgen.1003895
265. Zhu H, Zhou HL, Hasman RA, Lou H (2007) Hu proteins regulate polyadenylation by blocking sites containing U-rich sequences. J Biol Chem 282:2203–2210. doi:10.1074/jbc.M609349200
266. Zinszner H, Sok J, Immanuel D, Yin Y, Ron D (1997) TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling J Cell Sci 110 (Pt 15):1741–1750
267. Zucman J et al (1993a) EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 4:341–345. doi:10.1038/ng0893-341
268. Zucman J et al (1993b) Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J 12:4481–4487